Abstract OBJECTIVE: Lung cancer management has changed due to emergence of new imaging techniques and of multimodal therapies. Our purpose was to analyse how lung cancer evolved in surgical practice.
INTRODUCTION
Non-small-cell lung cancer (NSCLC), a rare malignancy 100 years ago, is now the leading cause of cancer death in the Western world [1] . The management of NSCLCs has undergone a rapid evolution during the last three decades due to the introduction and extensive application of modern imaging techniques, and emergence of multimodal therapies including platin-based chemotherapy and improved techniques of radiation therapy. We reviewed the characteristics of patients with NSCLC who underwent surgery over 24 years and analysed their changing patterns according to time.
PATIENTS AND METHODS
Between January 1983 and December 2006, 4668 patients underwent surgery for NSCLC in the Thoracic Surgery Department of a university hospital (Laennec Hospital, Paris, which was transferred to the newly built Georges Pompidou European Hospital, Paris, France, in 2000) and a medico-surgical centre (Cedar Centre, Boisguillaume, France). The patients were investigated in the pneumology departments of both these institutions, but some patients were also referred from pneumology departments of six other hospitals in which thoracic surgery was not available. The management of each patient was discussed in a 'Multidisciplinary Oncology Committee', and all of those who had been considered for surgery operated by similarly trained surgeons. The pre-operative workup included chest X-ray, bronchoscopy, spirometry, lung perfusion scan, computed tomography scan of the chest and a thorough search for distant metastases (including PET scan in the recent years). Mediastinoscopy was performed to exclude N3 disease or to confirm N2 involvement in some patients who entered in various neoadjuvant therapy protocols depending on the different referring centres. N3 disease and distant metastases precluded surgery, except for some rare cases with oligometastasis. Resection margins were routinely controlled by intra-operative frozen section studies when required and technically feasible. Complete mediastinal lymph node (LN) dissection was routinely performed since 1984. All patients underwent pain relief and chest physiotherapy during the post-operative period and the month following the hospital discharge. The staging system was the International Staging System for NSCLC adopted in 1997 [2] , and recently modified concerning the T and M [1, 3] when considering tumours >7 cm in diameter and the pulmonary nodules. Data were split into four time periods of 6 years each: 1983-88 = 832 patients, 1989-94 = 1148 patients, 1995-2000 = 1493 patients and 2001-06 = 1195 patients. We more specifically analysed and compared the epidemiological, pathological and prognostic characteristics of these groups.
Follow-up information was obtained from the hospital case records, using a questionnaire completed by the chest physician or general practitioner, or from death certificates. The main outcome was the overall survival, defined as the time interval between the date of operation and the date of death or the last follow-up visit for censored patients. Actuarial survival curves were estimated by the Kaplan-Meier method.
Statistical comparison between survival distributions was made using the log-rank test. Multivariate analysis was performed using the Cox proportional hazards model for overall survival analysis. Univariate analysis used the following outcome variables: gender, age, type of surgical resection, histology, T, type of N involvement, R (R2 being gross tumour left behind, R1 marginal microscopic invasion and R0 complete resection), neoadjuvant therapy (NAT) and adjuvant therapy (AT) and periods of time. For mediastinal LN involvement, the classification of Mountain and Dresler [4] was used. The N2 population was divided into 'single mediastinal LN station' N2, which is N2 involving a single station in either superior mediastinal nodes (2R + 4R or 3 or 4L) or aortic nodes (5 or 6) or inferior mediastinal nodes (7 or 8 or 9), and 'dual mediastinal LN station' N2, which is the involvement of two or more of any combination of the above-mentioned stations. 2R and 4R LN stations were grouped together because they are the components of the same anatomical LN chain [5] . All data analyses were conducted with the two-sided test: a P-value <0.05 was considered as statistically significant. The statistical software used for the analysis was SEM (Anticancer Centre Jean Perrin, Clermont-Ferrand, France) [6] . This retrospective study was approved by our Thoracic Surgery Society Ethic Committee (CERC). ). Mean follow-up duration was 72.8 (±48) months, and 65 patients (1.4%) were lost during follow-up. The overall 5-year and 10-year survival rates (5 y and 10 y) were 42 and 26.3%, respectively, for the whole population. The main epidemiological factors of poor prognosis were: male gender (5 y 40.5%, 10 y 24.8% vs. 47.1 and 32.5%, respectively, P = 0.00008), mean age >61 years (5 y 37.3%, 10 y 19.9% vs. 46.5 and 32.6%, respectively, P < 10 −6 ), pneumonectomy vs. lesser resection (5 y 32.5%, 10 y 19.6% vs. 49 and 31.8%, respectively, P < 10 −6 ), history of a previous malignancy (5 y 33.6%, 10 y 17.8% vs. 43.6 and 27.6%, respectively, P < 10 −6 ), history of coronary disease (5 y 36%, 10 y 21% vs. 45.3 and 29.9%, respectively, P = 0.0014) and post-operative complications (5 y 41.9%, 10 y 26.6% vs. 44.2 and 26.%, respectively, P = 0.07 and becoming significant when post-operative deaths, n = 204, were added to the complications).
RESULTS
The main characteristics according to periods of time are shown in Table 1 : increasing numbers of old patients and females, patients presenting with more and more frequent history of previous cancer or cardio-vascular disease and almost Table 2 : the number of exploratory thoracotomies and of pneumonectomies obviously decreased, whereas lesser resections and R0 resections were becoming progressively more and more frequent, with the exception of sleeve lobectomies whose frequency was relatively unchanged. Despite an increasing number of post-operative complications, the post-operative mortality rates remained stable over time (Table 1) .
The histological and pathological pattern of NSCLCs changed (Tables 2 and 3 ). Cases of adenocarcinomas and undifferentiated large-cell carcinomas increased whereas the frequency of SCCs regularly decreased. Surgery was more frequently performed to assess diagnosis of cancer despite more possibilities for preoperative diagnosis. Tumour size became significantly smaller, and T1-T2 tumours more frequent. During the first period, complete lymphadenectomy was performed in 72.8% of patients and increased progressively to 91% in the last period, whereas LN sampling decreased from (14-4.6%) as well as resection without lymphadenectomy (13.2-4.4%), which was highly significant (P = 10 −6 ). N0 tumours initially observed in 47.2% of patients rose to 61.2%, and as a counterpart, N1 and N2 tumours progressively became less frequent, 22.3-17.2% and 30.5-21.6%, respectively. The modification of the histology patterns concerning SCCs (n = 2154) and adenocarcinomas (1777) was partly responsible for the N and resection-type changes, N1 and pneumonectomy being more frequent than lesser resection in the case of SCC: 26.7% (n = 570) vs. 11.9% (209), and 45.7% (n = 985) vs. 21.5% (n = 382), respectively (P < 10 −6 ). Surgical management and multimodality treatment evolved over time with NAT, mainly chemotherapy, being performed in 24.9% of patients and AT in about 30% during the last period (Table 4) .
Five-year survival rates are shown in Table 5 : 5-year survival rates dramatically improved with time from 34.5% during the first period to 46.3% (P < 10 −6 ) during the last one. The increase was observed after lobectomy, in the case of Sleeve lobectomy rates were slightly decreasing as a whole (P = 0.016), but were stable between the first and the last period of time (P = 0.60).
a Surgery was diagnostic. b Pre-operative histology was the same as the one provided by post-operative pathology. The N was not histologically proven for 63 exploratory thoracotomies (all histologies were included).
adenocarcinoma, and also in the case of N0 and R0N0 patients. Five-year survival rates were unchanged after pneumonectomy, and in N1 and R0N1 patients. Survival rates increased for all N2 and also R0N2 patients, but the rates were particularly low during the first period, and stable during the three other periods (P = 0.30). Rates increased in the patients with SCCs without NAT, and were unchanged in those receiving NAT. Survival of patients receiving NAT and AT is shown in Table 6 . Long-term survivors and causes of death are shown in Table 7 : NSCLC-related causes of death were stable over time whereas deaths due to another cancer increased, and deaths due to the other causes decreased. NAT: neoadjuvant therapy; AT: adjuvant therapy; RT: radiation therapy; CT: chemotherapy; RCT: radiation and chemotherapy; CRT: chemo-radiation therapy. The use of multimodal treatment mainly including peri-operative CT was increasing with time, but surgery alone without other treatment always remained important. AT: adjuvant therapy; NAT: neoadjuvant therapy; RT: radiation therapy; CT: chemotherapy; RCT: radiation therapy and chemotherapy; neoadjuvant radiation therapy and chemotherapy with radiation therapy are not detailed because of limited case numbers. Numbers in parentheses denote number of patients; m: median in months.
Multivariate analysis confirmed that period of time was an independent factor of prognosis (P < 10 −6 ), just as important as N, R, tumour size, age, past history of another cancer and more important than the type of resection, histology, NAT (P = 0.00086) and AT (P = 0.048) ( Table 8 ).
COMMENTS
NSCLC is the subject of a large number of publications regarding all its different aspects, and particularly numerous are those reporting survival after medical or surgical treatment or both according to TNM classification. TNM classification changed during the past three decades (1986 [7] , 1997 [2] and 2009 [1] ), as well as some other characteristics (for instance age and sex) in NSCLC patients [8] . Despite this fact, few reports compared postsurgery survival in different time periods, the first report being issued in 1990 [9] . Two reports were published during the 1990s [10, 11] , based on the 1986 TNM classification, and four reports were published during the first decade of the new millennium [12] [13] [14] [15] , based on the 1997 TNM classification. The periods of time differed according to the studies: each year [9] , three periods of 5 years [10] , five periods of 4 years [11] , one period of 11 years and one of 7 years [12] , two periods of 10 years and one of 7 years [13] , one period of 4 years and two of 5 years [14] and one period of 10 years and four of 5 years [15] . We initially tried six periods of 4 years but abandoned because of the too many results it provided, to finally just consider four periods: the results were similar and comparable. More interestingly, the results on the evolving characteristics are not much different from one series to another in the literature despite the wide diversity of considered periods and demonstrate changing and evolving time trends. Since the first publication [9] , mean age was demonstrated to be increasing according to the periods of time as well as the frequency of adenocarcinomas. It was observed that the frequency of Stage I patients was increasing as was the number of female patients and 5-year survival rates, whereas the number of exploratory thoracotomies, pneumonectomies, post-operative deaths and incomplete resections was decreasing [10, 11] . Ferguson and Vigneswaran [13] observed an increasing number of patients with co-morbid factors and pre-operative chemotherapy and/or radiation therapy.
Our study confirmed most of these results, but in our series, post-operative mortality appeared unchanged and postoperative complications slightly increased. This increasing complication frequency may be explained by the combined facts that patients were older and older and presented with more and more associated co-morbidity. However, these results are not contradictory because post-operative mortality generally originates from complications, and unchanged post-operative mortality rates, when complication rates are increasing, may indicate the better post-operative care or improved management in the recent years.
Our study provided complementary results on general oncology: we observed that a past history of another cancer was increasingly more frequent in patients who underwent surgery for NSCLC. Although not surprising in a more ageing population, this oncological status is important and deserves to be considered nowadays in papers dealing with NSCLC: in effect, we observed that other cancer history is an independent factor of poorer prognosis confirmed by multivariate analysis (Table 8 ). In the same manner, we observed that occurrence of another cancer was an augmenting cause of later death in our series, whereas NSCLC-related cause of death remained stable and other causes of death decreased in recent years.
Our and the other studies demonstrated that the overall 5-year survival rates were improving from one period of time to 
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another, whatever its length. The patients are better selected over time because of new imaging and staging techniques, and many futile operations are thus avoided: the improved global 5-year survival rates are mainly the result of the Will Rogers phenomenon [16] . However, it is more difficult to explain why results were also improved in patients with pT1and pN0 ( p-Stage I), and pN2 cases ( p-Stage IIIA). One reason should be that the last period of follow-up was probably too short for many patients, which may have biased the final results. Another reason could be the more widely performed peri-operative NAT and AT in the recent years which may have favourably influenced the results, as may be anticipated from meta-analysis of previous prospective studies [17, 18] . This hypothesis is supported by our study: NAT was not a significant factor of good prognosis in univariate analysis (Tables 5 and 6 ) but proved effective in multivariate one (Table 8) , whereas AT was a significant factor of good prognosis in univariate analysis but the effect was not so important in multivariate analysis. However, it is noteworthy to stress that in our series, the results of surgery alone were also dramatically and significantly improved over time independent of NAT and AT (Table 6 ), whereas the techniques used were the same over the four periods and performed by similar trained surgeons. This suggests that the results obtained by peri-operative treatment modalities should be analysed taking into account that cancer presentation strongly changed and that patient selection largely improved during each 6-year period of time of the last 24 years. It should perhaps be advisable to consider the time-related factor of prognosis and to be circumspect in interpreting the multimodal treatment trials including surgery, the minimal duration of which commonly exceeds 6 years. To conclude, the clinico-pathological features of operated patients deeply changed with periods of time. The earlier stage at the time of diagnosis may explain the overall survival improvement, and better selection may be a more important factor of ameliorated prognosis than associated peri-operative treatments. Therefore, it should be advised to consider time-related factor of prognosis in the studies including surgery.
